MindWalk Holdings Corp.

IPA and its subsidiaries are now MindWalk. 

MindWalk is a global biologics discovery company integrating Bio-Native AI, deep data, and advanced lab research to help accelerate discovery and development of therapeutic, anti-drug, and diagnostic antibodies, peptide-based therapies, vaccines, and beyond. We deliver end-to-end solutions spanning target exploration, discovery, engineering, characterization, production, and humanization—available as full-service partnerships, existing-asset co-development, or modular SaaS access. We partner with leading biotech and pharmaceutical organizations, applying our unified biointelligence ecosystem to advance next-generation biologics for human health.